Guidance and quality standards Awaiting development
Showing 1 to 2 of 2
Title | Type |
---|---|
Deucravacitinib for treating active psoriatic arthritis TS ID 11981 | Technology appraisal guidance |
Sarilumab for treating polyarticular or oligoarticular juvenile idiopathic arthritis in people 2 to 17 years TS ID 10237 | Technology appraisal guidance |